mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |